Table 4.
Number of MSM being tested for STI/HIV in the national STI database and case-finding effectiveness
| |
N included |
Case finding effectiveness (%) |
Logistic regression |
||
|---|---|---|---|---|---|
|
Multivariate | |||||
| OR (95%CI) | p-value | ||||
|
HIV |
38,879 |
2.4 |
|
|
|
| Unnotified |
33,924 |
2.1 |
1.0 |
|
|
| Notified |
4,955 |
4.6 |
2.3* (1.9-2.6) |
|
<0.001 |
|
Chlamydia |
48,657 |
10.6 |
|
|
|
| Unnotified |
42,019 |
9.6 |
1.0 |
|
|
| Notified |
6,638 |
16.8 |
2.0** (1.8-2.1) |
|
<0.001 |
|
Gonorrhoea |
48,649 |
8.4 |
|
|
|
| Unnotified |
42,012 |
7.4 |
1.0 |
|
|
| Notified |
6,637 |
14.7 |
2.5*** (2.3-2.7) |
|
<0.001 |
|
Syphilis |
48,532 |
3.0 |
|
|
|
| Unnotified |
41,929 |
2.8 |
1.0 |
|
|
| Notified |
6,603 |
4.0 |
1.7*** (1.5-2.0) |
|
<0.001 |
|
Hepatitis B |
20,726 |
0.8 |
|
|
|
| Unnotified |
17,679 |
0.7 |
1.0 |
|
<0.001 |
| Notified | 3,047 | 1.2 | 1.7* (1.2-2.5) | ||
* No adjustments; ** Adjusted for previous STI, Known HIV + and symptoms;
*** Adjusted for symptoms; CI: confidence interval; OR: odds ratio.